Back
Design Therapeutics Stock Price Chart
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.
Sell
35
DSGN
Design Therapeutics
Last Price:
5.35
Seasonality Move:
-1.96%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and DSGN is experiencing selling pressure, which indicates risk of future bearish movement.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.53 | Sell |
| 20-day SMA: | 5.32 | Buy |
| 50-day SMA: | 4.92 | Buy |
| 200-day SMA: | 3.69 | Buy |
| 8-day EMA: | 5.45 | Sell |
| 20-day EMA: | 5.33 | Buy |
| 50-day EMA: | 4.94 | Buy |
| 200-day EMA: | 4.29 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 52.04 | Buy |
| Chaikin Money Flow: | -110030 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.83 - 5.65) | Buy |
| Bollinger Bands (100): | (3.75 - 5.13) | Buy |
Design Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.33 while DSGN 8-day simple moving average is 5.53, which is a Sell signal.
- The stock price of DSGN is 5.33 while Design Therapeutics 20-day SMA is 5.32, which makes it a Buy.
- Design Therapeutics 50-day simple moving average is 4.92 while DSGN share price is 5.33, making it a Buy technically.
- DSGN stock price is 5.33 and Design Therapeutics 200-day simple moving average is 3.69, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
35
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a Sell
The current Design Therapeutics [DSGN] share price is $5.33. The Score for DSGN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
301.79M
Price in USD:
5.33
Share Volume:
135.92K
Design Therapeutics 52-Week Range
52-Week High:
6.91
52-Week Low:
1.96
Sell
35
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?
The Design Therapeutics stock price is 5.33 USD today. -
Will DSGN stock go up or go down?
Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Design Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.33 while DSGN 8-day exponential moving average is 5.45, which is a Sell signal.
- The stock price of DSGN is 5.33 while Design Therapeutics 20-day EMA is 5.33, which makes it a Buy.
- Design Therapeutics 50-day exponential moving average is 4.94 while DSGN share price is 5.33, making it a Buy technically.
- DSGN stock price is 5.33 and Design Therapeutics 200-day simple moving average is 4.29, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
- DSGN Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Design Therapeutics is a Buy
- Design Therapeutics Relative Strength Index (RSI) is 52.04, which suggest Design Therapeutics is overbought
- The Bollinger Bands (25) for Design Therapeutics is (4.83 - 5.65), which suggest Design Therapeutics is a Buy
- The Bollinger Bands (100) for Design Therapeutics is (3.75 - 5.13), which suggest Design Therapeutics is a Buy
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.